Healthward Bound
  • Health Checklist
  • Checklist Component & Scoring
  • Vital Statistics & Life Expectancy
    • Vital Statistics
    • Life Expectancy
  • Medical History
    • Personal
    • Family
  • Lifestyle
  • Physical Examinations
    • General Appearance
    • Eyes Ears Nose & Face
    • Mouth Pharynx & Neck
    • Upper Limbs
    • Thorax
    • Abdomen
    • Lower Limbs
  • Blood Tests
  • Urinalysis
  • Common Preventive Screens
  • Vaccination Status
  • Social & Environmental Factors
  • Genome Profiling Status
  • Microbiome Profiling Status
  • Biological vs Chronological Age
  • Comprehensive Scoring
  • Blog
  • Who We Are
  • Get In Touch
  • Danh mục kiểm tra sức khỏe
  • Danh mục kiểm tra và cách tính điểm số
  • Thống kê sinh tử và tuổi thọ
    • Thống kê sinh tử
    • Tuổi thọ dự kiến
  • Bệnh Sử
    • Cá nhân
    • Gia đình
  • Lối sống
  • Khám sức khỏe
    • Tổng thể bề ngoài
    • Mắt, tai, mũi & mặt
    • Miệng, Họng & Cổ
    • Chi trên
    • Lồng ngực
    • Bụng
    • Chi dưới
  • Xét nghiệm máu
  • Xét nghiệm nước tiểu
  • Các sàng lọc dự phòng
  • Tình trạng tiêm chủng
  • Yếu tố xã hội và môi trường
  • Hồ sơ bộ gen
  • Hồ sơ hệ vi sinh vật
  • Đánh giá tuổi sinh học so với năm tuổi
  • Blog Tiếng Việt
  • Health Checklist
  • Checklist Component & Scoring
  • Vital Statistics & Life Expectancy
    • Vital Statistics
    • Life Expectancy
  • Medical History
    • Personal
    • Family
  • Lifestyle
  • Physical Examinations
    • General Appearance
    • Eyes Ears Nose & Face
    • Mouth Pharynx & Neck
    • Upper Limbs
    • Thorax
    • Abdomen
    • Lower Limbs
  • Blood Tests
  • Urinalysis
  • Common Preventive Screens
  • Vaccination Status
  • Social & Environmental Factors
  • Genome Profiling Status
  • Microbiome Profiling Status
  • Biological vs Chronological Age
  • Comprehensive Scoring
  • Blog
  • Who We Are
  • Get In Touch
  • Danh mục kiểm tra sức khỏe
  • Danh mục kiểm tra và cách tính điểm số
  • Thống kê sinh tử và tuổi thọ
    • Thống kê sinh tử
    • Tuổi thọ dự kiến
  • Bệnh Sử
    • Cá nhân
    • Gia đình
  • Lối sống
  • Khám sức khỏe
    • Tổng thể bề ngoài
    • Mắt, tai, mũi & mặt
    • Miệng, Họng & Cổ
    • Chi trên
    • Lồng ngực
    • Bụng
    • Chi dưới
  • Xét nghiệm máu
  • Xét nghiệm nước tiểu
  • Các sàng lọc dự phòng
  • Tình trạng tiêm chủng
  • Yếu tố xã hội và môi trường
  • Hồ sơ bộ gen
  • Hồ sơ hệ vi sinh vật
  • Đánh giá tuổi sinh học so với năm tuổi
  • Blog Tiếng Việt

Leading  edge  topics

Tiếng Việt

A balancing act: Keeping your gut healthy

12/3/2024

0 Comments

 
Picture
Introduction
​
Over the past decade, scientific research has increasingly underscored the central role of the gut microbiota in maintaining overall health. This complex and dynamic ecosystem of microorganisms does far more than assist with digestion. It actively influences immune regulation, metabolic balance, hormone signaling, and even brain function through the gut–brain axis. As a result, the gut microbiome is now recognized as a critical determinant of long-term health and disease risk.
 
A growing body of evidence links gut microbiota imbalance, commonly referred to as dysbiosis, to a wide range of chronic diseases, including autoimmune conditions, metabolic disorders such as obesity and type 2 diabetes, neurological disorders, and certain cancers [1]. These associations suggest that disturbances in the gut ecosystem may not merely accompany disease, but actively contribute to its development and progression.
 
Despite this rapidly expanding scientific consensus, public awareness of gut dysbiosis remains limited, and clear, actionable guidance from government health agencies and medical societies is still lacking. While microbiome research is advancing at an unprecedented pace, standardized clinical recommendations for screening, prevention, and intervention have yet to be widely adopted. This gap raises important questions about how individuals can apply emerging microbiome insights to everyday health decisions and preventive care [2].
 
In the absence of formal guidelines, individuals interested in optimizing gut health must often navigate this evolving field independently. Preventive medicine offers a promising framework, emphasizing early identification of microbial imbalances and timely interventions before disease becomes established. Potential strategies span a broad spectrum, from dietary modifications and lifestyle changes, to the use of probiotics and prebiotics, and, in selected clinical contexts, fecal microbiota transplantation (FMT) as a therapeutic option for individuals with established microbiome-related diseases [3].
 
This article explores the scientific foundations of gut health, the implications of microbiome imbalance, and practical strategies for maintaining microbial balance. In doing so, it aims to empower readers to make informed decisions about gut health in a landscape where scientific knowledge is advancing faster than regulatory guidance.

References
[1] Afzaal M, Saeed F, Shah YA, Hussain M, Rabail R, Socol CT, Hassoun A, Pateiro M, Lorenzo JM, Rusu AV, Aadil RM. Human gut microbiota in health and disease: Unveiling the relationship. Front. Microbiol. 2022; 13;  https://doi.org/10.3389/fmicb.2022.999001
[2] Abeltino A, Hatem D, Serantoni C, Riente A, De Giulio MM, De Spirito M, De Maio F, Maulucci G. Unraveling the Gut Microbiota: Implications for Precision Nutrition and Personalized Medicine. Nutrients. 2024; 16(22):3806. https://doi.org/10.3390/nu16223806
[3] Andary CM. et al. Dissecting mechanisms of fecal microbiota transplantation efficacy in disease. Trends in Molecular Medicine, 2024; 30 (3): 209 – 222. DOI: 10.1016/j.molmed.2023.12.005
Gut Dysbiosis Is a Growing Health Concern
 
The human gut microbiota is a highly diverse and dynamic ecosystem of microorganisms that plays a central role in maintaining health. Gut dysbiosis refers to a state of imbalance in this ecosystem, in which changes in the composition, diversity, or functional capacity of microbial communities disrupt normal host–microbe interactions [1,2]. Increasing evidence shows that dysbiosis is present across a wide spectrum of chronic diseases, many of which are listed later in this article.
 
Under healthy conditions, commensal bacteria—including species from the genera Lactobacillus and Bifidobacterium—support gut integrity and immune homeostasis. These bacteria produce key metabolites known as short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate (see Table 1). SCFAs serve as an energy source for colonocytes, strengthen the intestinal barrier, regulate immune responses, and exert anti-inflammatory effects throughout the body [3].
 
By contrast, dysbiosis often involves an expansion of pathobionts—microorganisms that are typically harmless but can become pathogenic under certain conditions. Many pathobionts have the ability to degrade the gut mucin layer, a protective barrier that lines the intestinal epithelium and prevents direct contact between microbes and host cells [4].
 
Breakdown of the Gut Barrier
 
The mucin layer is essential for maintaining intestinal immune tolerance. When intact, it limits microbial translocation and prevents inappropriate immune activation. However, excessive growth of mucin-degrading bacteria—such as Akkermansia muciniphila (when overabundant), Bacteroides fragilis, Escherichia coli, Clostridioides difficile, and Fusobacterium species—can thin this protective layer.
As the mucin barrier erodes, bacteria and their metabolites gain access to the epithelial surface and, in some cases, the systemic circulation. This microbial translocation triggers immune activation and chronic inflammation, contributing to diseases such as inflammatory bowel disease (IBD), colorectal cancer, metabolic syndrome, and other systemic inflammatory conditions.
 
Common Causes of Gut Dysbiosis
 
Gut dysbiosis can arise from multiple, often interacting, factors [5]:
  • Antibiotic use: Broad-spectrum antibiotics disrupt microbial diversity and can promote overgrowth of opportunistic pathogens
  • Dietary patterns: Western diets high in fat and refined sugars but low in fiber reduce SCFA-producing bacteria
  • Infections: Acute or chronic infections can permanently alter microbial community structure
  • Stress and lifestyle factors: Psychological stress, disrupted sleep, and sedentary behavior affect gut motility and microbial balance
  • Aging: Natural age-related changes often reduce microbial diversity and beneficial species [6]
 
Can Dysbiosis Be Reversed?
 
Encouragingly, gut dysbiosis is often partially or fully reversible, particularly when addressed early. Evidence-based strategies include:
  • Lifestyle interventions: Regular physical activity, stress reduction, and adequate sleep support microbiome stability
  • Dietary modifications: High-fiber, plant-rich diets promote SCFA production and microbial diversity
  • Probiotics and prebiotics: Probiotics introduce beneficial microbes, while prebiotics selectively nourish them [7]
  • Fecal microbiota transplantation (FMT): FMT is highly effective for recurrent C. difficile infection and is being explored for other dysbiosis-associated diseases [8]
 
Key Takeaway
 
Gut dysbiosis disrupts the delicate balance between beneficial commensal bacteria and pathobionts, compromises the integrity of the intestinal barrier, and promotes inflammation that can drive disease. By understanding the causes of dysbiosis and applying targeted, evidence-based interventions, restoration of a healthier gut microbiota is achievable, offering meaningful opportunities for disease prevention and improved long-term health.
​
References
[1] Sommer, F, & Bäckhed, F. The gut microbiota—masters of host development and physiology. Nature Reviews Microbiology. 2013; 11(4), 227–238.  https://doi.org/10.1038/nrmicro2974
[2] Cleveland Clinic: Dysbiosis
[3] Bedu-Ferrari C, Biscarrat P, Pepke F, Vati S, Chaudemanche C, Castelli F, Chollet C, Rué O, Hennequet-Antier C, Langella P, Cherbuy C. In-depth characterization of a selection of gut commensal bacteria reveals their functional capacities to metabolize dietary carbohydrates with prebiotic potential. mSystems 2024; 9: e01401-23. https://doi.org/10.1128/msystems.01401-23.
[4] Yamaguchi, M, Yamamoto, K. Mucin glycans and their degradation by gut microbiota. Glycoconj. J. 2023; 40, 493–512. https://doi.org/10.1007/s10719-023-10124-9
[5] Healthline: What causes dysbiosis and how is it treated?
[6] Ravikrishnan, A., Wijaya, I., Png, E. et al. Gut metagenomes of Asian octogenarians reveal metabolic potential expansion and distinct microbial species associated with aging phenotypes. Nat. Commun. 2024; 15, 7751. https://doi.org/10.1038/s41467-024-52097-9
[7] Bermúdez-Humarán, L.G., Chassaing, B. & Langella, P. Exploring the interaction and impact of probiotic and commensal bacteria on vitamins, minerals, and short chain fatty acids metabolism. Microb. Cell Fact. 2024; 23, 172. https://doi.org/10.1186/s12934-024-02449-3
[8] Cleveland Clinic: Fecal Transplant
Comprehensive List of Conditions Strongly Linked to Dysbiosis [1,2]
  • Rheumatoid Arthritis (RA)
  • Inflammatory Bowel Disease (IBD)
  • Irritable Bowel Syndrome (IBS)
  • Type 1 Diabetes
  • Obesity
  • Colorectal Cancer
  • Small Intestinal Bacterial Overgrowth (SIBO)
  • Cardiovascular Diseases
  • Neurological Disorders (including Alzheimer's Disease [3,4] and Parkinson's Disease [5,6])
  • Chronic Fatigue Syndrome
  • Metabolic Syndrome
  • Asthma and Allergies
  • Autism Spectrum Disorder (ASD)
  • Chronic Liver Disease
____________________________________________________________
References:
[1] Cleveland Clinic: Dysbiosis
[2] WebMD: What is dysbiosis
[3] Thakkar, A, Vora, A, Kaur, G et al. Dysbiosis and Alzheimer’s disease: role of probiotics, prebiotics and synbiotics. Naunyn-Schmiedeberg's Arch. Pharmacol. 2023; 396, 2911–2923. https://doi.org/10.1007/s00210-023-02554-x
[4] Oral Dysbiosis and Alzheimer’s Disease Risk
 [5] Medical News Today: Study in humans confirms link between Parkinson's and gut bacteria imbalance.
[6] Munoz-Pinto MF, Candeias E, Melo-Marques I et al. Gut-first Parkinson’s disease is encoded by gut dysbiome. Mol. Neurodegeneration. 2024; 19, 78. https://doi.org/10.1186/s13024-024-00766-0


Table 1. Selected Short Chain Fatty Acid (SCFA) producing bacterial specie

Genus

Species

Lactobacillus

johnsonii

 

acidophilus

 

gasseri

 

casei

 

paracasei

 

rhamnosus

 

salivarus

 

fermentum

 

plabtarum

Bifidobacterium

bifidum

 

longum

 

breve

 

adolescentis

 

animalis

Faecalibacrerium

prautnizii

Roseburia

inulinivorans

Anaerobutyricum

halii

Bacteroides

xylanisplvens

 


Table 2. Selected mucin degrading bacterial specie

Family

Genus

Species

Akkermansiaceae

Akkermansia

muciniphilia

Bacteroidaceae

Bacteroides

Fragilis

Enterobacteriaceae

Escherichia

Many species from the Enterobacteriaceae family

 

Klebsiella

 

 

Proteus

 

 

Salmonella

 

 

Shigella

 

 

Yersinia

 

Enterococcaceae

Bavariicoccus

Many species from the Enterococcaceae family

 

Catellicoccus

 

 

Enterococcus

 

 

Melossococcus

 

 

Pilibacter

 

 

Tetragenococcus

 

 

Vagococcus

 

Peptococcaceae

Peptococcus

Many species from the Peptococcaceae family

 

Peptostreptococcus

 

 

Ruminococcus

 

Peptostreptococcaceae

Clostridiodes

Difficile (syn. Clostridium difficile)

Clostridiaceae

Clostridium

disporicum

 

 

tertium

 

Paraclostridium

benzoeliticum

Oscillospriraceae

Anaerotruncus

colihominis

Erysipelotrichaceae

Holdemania

filiformis

 

 

massilliensis

Eggerthellaceae

Eggerthella

Lenta and others

Fusobacteriaceae

Fusobacterium

Many species from the Fusobacterium genus

 


Diagnosis: How Gut Dysbiosis Is Evaluated
 
In clinical practice, the evaluation of gut dysbiosis is most often prompted by gastrointestinal symptoms, rather than by routine screening. When patients present with digestive complaints or systemic symptoms suspected to be microbiome-related, healthcare providers may use a range of established diagnostic tools to investigate potential microbial imbalances.
 
Breath Testing
 
Breath tests are commonly used to assess conditions such as small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption [1]. These tests are particularly appropriate for patients with:
  • Chronic bloating or abdominal discomfort
  • Excessive gas
  • Constipation or diarrhea
  • Unexplained abdominal pain
 
During testing, patients ingest a specific carbohydrate substrate—such as lactose, fructose, sorbitol, glucose, or lactulose—depending on the suspected condition. Elevated levels of hydrogen and/or methane measured in exhaled breath reflect abnormal microbial fermentation in the small intestine, supporting a diagnosis of SIBO or malabsorption syndromes [2].
 
Biomarker-Based Testing
 
Another diagnostic approach involves biomarkers associated with gut barrier integrity and microbial function:
  • Zonulin: A protein that regulates tight junctions between intestinal epithelial cells. Elevated zonulin levels in stool or blood may indicate increased intestinal permeability (“leaky gut”), which is often associated with dysbiosis.
  • Short-chain fatty acids (SCFAs): Reduced levels of key SCFAs such as butyrate and propionate in stool or blood may reflect diminished activity of beneficial, fiber-fermenting bacteria.
 
While these biomarkers do not diagnose dysbiosis on their own, they provide functional insights into gut health that complement microbial profiling.
 
Stool-Based Testing
 
Stool analysis can be performed at varying levels of depth and complexity:
 
  • Targeted stool cultures: Used to identify specific pathogens or bacterial overgrowth, such as Clostridioides difficile or pathogenic Escherichia coli.
  • Microbiome sequencing:
    • 16S rRNA sequencing provides an overview of bacterial composition and diversity.
    • Shotgun (next-generation) sequencing analyzes all microbial DNA in the sample—including bacteria, viruses, fungi, and archaea—offering a more comprehensive microbiome profile [3,4].
  • Comprehensive Stool Analysis (CSA):
    At the most advanced level, CSA combines microbiome profiling with multiple functional markers, including:
    • Digestive markers: pancreatic elastase, fat and protein malabsorption
    • Inflammatory markers: calprotectin, lactoferrin
    • Metabolic markers: stool pH, β-glucuronidase
    • Gut barrier markers: zonulin, secretory IgA
    • Short-chain fatty acids (SCFAs) [5–7]
 
CSA is typically used in complex or persistent cases and provides a multidimensional assessment of gut function, not just microbial composition.
 
Diagnostic Uncertainty in Asymptomatic or At-Risk Individuals
 
A significant challenge arises for individuals who do not have overt gastrointestinal symptoms but exhibit early signs of diseases associated with dysbiosis, or who are genetically predisposed based on family history. In these situations, there is no consensus guidance from government health agencies or major medical societies regarding when—or whether—to evaluate gut microbiota status.
 
Because causal relationships between dysbiosis and many chronic diseases are still being clarified, clinical recommendations remain cautious. As a result, decisions about testing are typically made collaboratively between patients and healthcare providers, informed by emerging evidence rather than formal guidelines. The medical literature reflects this uncertainty, with well-argued perspectives both for and against routine microbiome testing in asymptomatic individuals [8].
 
Direct-to-Consumer Microbiome Testing
 
In the absence of standardized clinical pathways, some individuals choose to explore direct-to-consumer (DTC) microbiome testing, a rapidly expanding sector of personalized health [9,10]. While these tests can offer educational insights, interpretation can be complex and potentially misleading without proper context. For this reason, results are best reviewed with the support of qualified healthcare professionals, and when genetic data are involved, licensed genetic counselors [11].
 
Looking Ahead
 
Diagnosing gut dysbiosis remains an evolving area of medicine. Current tools are most useful when guided by symptoms, risk factors, and clinical judgment rather than used indiscriminately. In the next section, we will explore practical strategies for supporting and improving gut microbiota balance, ranging from lifestyle interventions to therapeutic options.

References
[1] Small Intestinal Bacterial Overgrowth. [Updated 2023 Apr 17]. Sorathia SJ, Chippa V, Rivas JM. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK546634/
[2] WebMD: What To Know About Hydrogen Breath Tests
[3] Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians. Allaband C et al. Clinical Gastroenterology and Hepatology. 2019; 17 (2), 218 – 230. DOI: 10.1016/j.cgh.2018.09.017
[4] Clinician Guide to Microbiome Testing. Staley C, Kaiser T & Khoruts A. Dig. Dis. Sci. 2018; 63, 3167–3177. https://doi.org/10.1007/s10620-018-5299-6
[5] Genova Diagnostics: GI Effects
[6] Doctor’s Data: Comprehensive Stool Analysis
[7] Diagnostic Solutions Laboratory: GI-MAP
[8] Dr. Ruscio DC: Should You Use a Stool Test to Check Your Gut Health?
[9] Rupa Health: Revolutionizing Gut Health: The Rise of Microbiome Testing Companies and Their Impact on Personalized Medicine. Scott Bingman. October 28, 2024.
[10] Microbiome Therapeutics Innovation Group (MTIG)
[11] National Society of Genetic Counselors: Find a genetic counselor  
Lifestyle Interventions to Support Gut Health
 
Regardless of whether gut dysbiosis has been formally diagnosed, individuals can take meaningful steps to support their gut microbiota through everyday lifestyle choices. Three modifiable factors--physical activity, sleep quality, and stress management—have consistently been shown to influence microbial diversity, gut barrier integrity, and systemic inflammation.
 
Exercise and the Gut Microbiota
 
A growing body of research demonstrates that regular physical activity enhances gut microbial diversity, a hallmark of a resilient and healthy microbiome [1]. Exercise has been associated with increased abundance of beneficial bacterial taxa, including Faecalibacterium prausnitzii, Akkermansia muciniphila, Bacteroides, and Roseburia. These microbes are linked to anti-inflammatory effects, improved gut barrier function, and metabolic health.
 
Mechanistically, exercise promotes the growth of butyrate-producing bacteria, increasing the production of short-chain fatty acids (SCFAs). SCFAs provide energy to colonocytes, reinforce intestinal tight junctions, and help regulate immune responses. Studies in both humans and animal models consistently show that sedentary behavior is associated with reduced microbial diversity, whereas physically active individuals exhibit greater microbial richness and resilience to dysbiosis [2].
 
Current public health guidelines recommend that adults engage in at least 150 minutes of moderate-intensity exercise per week, or 75 minutes of vigorous-intensity activity, or an equivalent combination of both [3]. Even modest increases in physical activity can yield measurable benefits for gut health.
 
Sleep and Gut Health
 
Sleep plays a critical role in maintaining microbiome stability and gut barrier integrity [4]. Adequate and consistent sleep supports normal immune function and helps prevent excessive intestinal permeability, which can otherwise promote inflammation and dysbiosis [5].
 
Emerging research highlights bidirectional interactions between sleep and the gut microbiome. Specific bacterial taxa, such as Lachnospiraceae UCG-004 and Odoribacter, have been associated with longer sleep duration and better sleep quality, suggesting that a healthy microbiome may actively support restorative sleep [6]. Conversely, chronic sleep deprivation and irregular sleep patterns can disrupt microbial balance and increase susceptibility to metabolic, inflammatory, and neurological disorders.
For adults aged 18 and older, expert consensus recommends at least 7 hours of sleep per night to support overall health, including gut health [7].
 
Stress Management and the Gut–Brain Axis
 
Chronic psychological stress has well-documented negative effects on gut health through the gut–brain axis. Stress alters gut motility, reduces mucus secretion, and increases intestinal permeability, creating conditions that favor dysbiosis. Elevated cortisol levels—a physiological marker of stress—have been associated with reductions in beneficial bacteria such as Lactobacillus and Bifidobacterium [8].
 
Stress-reduction strategies can help counteract these effects. Practices such as mindfulness meditation, yoga, controlled breathing, and relaxation techniques modulate the hypothalamic–pituitary–adrenal (HPA) axis and reduce systemic inflammation [9]. Clinical and experimental studies suggest that these interventions may help restore microbial diversity and improve gut function. General, evidence-based guidance on identifying and managing stressors is available through public health resources [10].
 
Key Takeaway
 
Exercise, sleep, and stress management represent accessible and powerful tools for maintaining gut microbiota balance. By fostering microbial diversity, supporting beneficial bacterial species, and reducing inflammation, these lifestyle interventions empower individuals to take an active role in preserving gut health. Importantly, the benefits extend beyond the digestive system, contributing to improved metabolic, immune, and mental health.
For a broader discussion of lifestyle factors influencing overall health, readers are encouraged to consult the Lifestyle section of this website.

References
[1] Clarke SF, Murphy EF, O'Sullivan O, et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014 ; 63 :1913-1920. https://doi.org/10.1136/gutjnl-2013-306541
[2] Khaledi, M, Darvishi, M, Sameni, F et al. Association between exercise and changes in gut microbiota profile: a review. Sport Sci. Health. 2024; 20: 273–286. https://doi.org/10.1007/s11332-023-01132-1
[3] What Counts as Physical Activity for Adults
[4] Kado, DM. Night-to-night sleep duration variability and gut microbial diversity: more evidence for a brain-gut microbiome-sleep connection. Sleep. 2024; 47(3), zsae005, https://doi.org/10.1093/sleep/zsae005
[5] Smith RP, Easson C, Lyle SM, Kapoor R, Donnelly CP, Davidson EJ, Parikh E, Lopez JV, Tartar JL. Gut microbiome diversity is associated with sleep physiology in humans. PLoS One. 2019;14(10): e0222394. doi: 10.1371/journal.pone.0222394. PMID: 31589627; PMCID: PMC6779243.
[6] Yue M, Jin C, Jiang X, Xue X, Wu N, Li Z, Zhang L. Causal Effects of Gut Microbiota on Sleep-Related Phenotypes: A Two-Sample Mendelian Randomization Study. Clocks Sleep. 2023; 5(3):566-580. doi: 10.3390/clockssleep5030037. PMID: 37754355; PMCID: PMC10527580.
[7] How much sleep do you need. Eric Suni & Abhinav Singh. Updated May 13, 2024.
[8] Almand, AT, Anderson, AP, Hitt, BD et al. The influence of perceived stress on the human microbiome. BMC Res. Notes. 2022; 15: 193. https://doi.org/10.1186/s13104-022-06066-4
[9] Chrousos, G. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 2009; 5: 374–381. https://doi.org/10.1038/nrendo.2009.106
[10] CDC: Stress management
Dietary Modifications to Restore and Maintain Gut Health
 
Diet is one of the most powerful and modifiable determinants of gut microbiota composition and function. Targeted dietary changes can help restore microbial balance in individuals with dysbiosis and support long-term gut health even in those without a formal diagnosis. Effective dietary correction begins with identifying imbalances and implementing evidence-based modifications that promote beneficial microbial growth while minimizing pro-inflammatory influences.
 
Identifying Dietary Imbalances

A comprehensive dietary assessment is often the first step in addressing dysbiosis. Registered dietitians or nutrition professionals can provide personalized guidance by evaluating dietary patterns, nutrient intake, and symptom associations using tools such as food frequency questionnaires (FFQs) or dietary recalls [1,2]. These assessments commonly identify deficiencies in dietary fiber, excess intake of ultra-processed foods, or imbalances in fat quality.
 
For individuals without access to professional guidance, self-monitoring can be a practical alternative. Food diaries and nutrition-tracking apps (e.g., MyFitnessPal, Lifesum, Cronometer, MyNetDiary) allow users to identify patterns such as low fiber intake, high added sugar consumption, or insufficient plant diversity. Tracking gastrointestinal symptoms, such as bloating, constipation, or irregular bowel movements, alongside food intake may also help uncover dietary triggers. As an initial step, following broadly accepted nutritional principles, prioritizing whole foods and minimizing processed products—can yield meaningful benefits.
 
Corrective Dietary Strategies
 
Dietary fiber is the cornerstone of a gut-supportive diet. High-fiber intake has consistently been shown to increase microbial diversity and stimulate the production of short-chain fatty acids (SCFAs), which play a central role in maintaining gut barrier integrity and immune regulation [3]. Fiber-rich foods include fruits, vegetables, legumes, whole grains, and prebiotic-containing foods such as garlic, onions, bananas, and asparagus.
 
In contrast, diets high in refined sugars and low in fiber are associated with reduced microbial diversity, increased intestinal inflammation, and greater susceptibility to dysbiosis [4]. Excessive intake of sugary snacks and ultra-processed foods can favor the growth of pathogenic bacteria. Replacing these foods with nutrient-dense alternatives—such as nuts, seeds, and minimally processed snacks—can help rebalance the microbiome.
 
Fat quality also matters. Diets rich in saturated fats have been shown to negatively affect gut microbial composition, whereas omega-3 fatty acids promote microbial diversity and support anti-inflammatory bacterial populations [5]. Healthier fat sources include fatty fish (e.g., salmon, mackerel), flaxseeds, chia seeds, and walnuts.
 
Alcohol consumption is another important consideration. Excessive alcohol intake disrupts gut microbial balance and increases intestinal permeability. Reducing alcohol intake to recommended limits—or eliminating it altogether—can significantly benefit gut health [6].
 
Finally, adequate hydration supports digestion and intestinal function. While individual needs vary, general guidance suggests a total daily fluid intake (from all sources) of approximately 3.7 liters for men and 2.7 liters for women, with adjustments for physical activity, climate, and health status [7,8].
 
When Diet Alone Is Not Enough
 
While lifestyle and dietary modifications are foundational, they may not be sufficient in all cases—particularly in individuals with established dysbiosis or chronic disease. In such situations, probiotics and other targeted interventions may be considered as the next step, which will be discussed in the following section.
​
References
[1] Search for a dietician.
[2] Find a nutrition expert.
[3] The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease. Makki, Kassem et al.. Cell Host & Microbe.2018; 23(6), 705 – 715. https://doi.org/10.1016/j.chom.2018.05.012
[4] Singh, R.K., Chang, HW., Yan, D. et al. Influence of diet on the gut microbiome and implications for human health. J. Transl. Med. 2017; 15, 73. https://doi.org/10.1186/s12967-017-1175-y
[5] Watson H, Mitra S, Croden FC, et al. A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota. Gut. 2018; 67:1974-1983. https://doi.org/10.1136/gutjnl-2017-314968
[6] CDC: About moderate alcohol use.
[7] Michael N. Sawka, Samuel N. Cheuvront, Robert Carter, Human Water Needs, Nutrition Reviews. 2005; 63, Issue suppl_1, S30–S39, https://doi.org/10.1111/j.1753-4887.2005.tb00152.x
[8] MedicalNews Today: How much water should you drink a day?
Probiotics: Supporting Gut Microbiota Balance
 
Probiotics—defined as live microorganisms that confer health benefits when consumed in adequate amounts—represent a promising intervention for individuals with gut dysbiosis. When lifestyle changes and dietary modifications alone are insufficient, probiotics may help restore microbial balance, enhance gut barrier function, and modulate immune responses [1].
 
Patients generally encounter two main probiotic sources: fermented foods and dietary supplements. Each approach offers distinct advantages and limitations, and in many cases, clinical guidance is advisable to ensure appropriate selection, dosing, and safety.
 
Probiotics from Fermented Foods
 
Traditional fermented foods—such as yogurt, kefir, sauerkraut, kimchi, and miso—naturally contain live microorganisms that can support gut health [2]. These foods commonly harbor beneficial genera such as Lactobacillus and Bifidobacterium, which are associated with improved microbial diversity and intestinal homeostasis [3].
 
Advantages
  • Easily incorporated into daily meals
  • Part of long-standing dietary traditions
  • Provide additional nutrients beyond probiotics
 
Limitations
  • Probiotic content varies widely by product, preparation method, and storage
  • Specific strains and colony counts are often unknown
  • Not all fermented foods contain live cultures at the time of consumption
 
As a result, fermented foods are best viewed as a foundational, supportive strategy rather than a precise therapeutic intervention.
 
Probiotics as Dietary Supplements
 
Probiotic supplements are available in capsules, tablets, powders, and liquids and typically contain defined bacterial or yeast strains at specified concentrations. Commonly studied strains include Lactobacillus rhamnosus GG, Bifidobacterium breve, and Saccharomyces boulardii, each associated with specific clinical indications such as antibiotic-associated diarrhea, immune modulation, or gastrointestinal symptom relief [4].
 
Advantages
  • Known strains and standardized dosing
  • Targeted use for specific conditions
  • Easier comparison across products
 
Limitations
  • Variable quality, viability, and labeling accuracy
  • Classified as dietary supplements rather than medications
  • Not regulated by the FDA with the same rigor as pharmaceuticals [5]
 
Because of these limitations, it is essential to select reputable brands and consult with a healthcare provider before initiating supplementation—particularly for individuals who are immunocompromised, elderly, or managing chronic disease [6].
 
This need for professional guidance becomes even more important for individuals using direct-to-consumer microbiome testing services, which often generate extensive reports and recommend multiple supplements, including prebiotics and probiotics. Without expert interpretation, the volume of information and product options can be overwhelming and may lead to inappropriate or redundant interventions.
 
Live Biotherapeutic Products (LBPs): A Distinct Regulatory Category
 
It is important to distinguish conventional probiotics from Live Biotherapeutic Products (LBPs), a regulatory category recently defined by the U.S. Food and Drug Administration. LBPs are biological products that:
  1. Contain live organisms (such as bacteria),
  2. Are intended to prevent, treat, or cure a disease or condition in humans, and
  3. Are not vaccines.
Unlike dietary supplements, LBPs must undergo rigorous clinical trials and receive regulatory approval before marketing. Although some probiotics may eventually qualify as LBPs for specific disease indications, no probiotic has yet been approved under this category.
 
Key Takeaway
 
Probiotics can be a valuable adjunct for supporting gut microbiota balance, particularly when diet and lifestyle changes are insufficient. Fermented foods offer a natural, accessible entry point, while dietary supplements allow for more targeted interventions. However, probiotic use should be personalized, evidence-based, and guided by qualified healthcare professionals, especially in the absence of standardized clinical guidelines.

References
[1] Cleveland Clinic: Probiotics
[2] Veryell Health: 20 Probiotic Foods With Good Bacteria. Amber J. Tresca. Published September 22, 2023
[3] WebMD: Top Foods High in Probiotics
[4] Sanders, ME, Merenstein, DJ, Reid, G et al. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat. Rev. Gastroenterol. Hepatol. 2019; 16, 605–616. https://doi.org/10.1038/s41575-019-0173-3
[5] Doron S, Snydman DR. Risk and Safety of Probiotics, Clinical Infectious Diseases. 2015; 60, Issue suppl_2, S129–S134, https://doi.org/10.1093/cid/civ085
[6] Clinical Guide to Probiotic Products Available in USA
Prebiotics and Synbiotics: Enhancing Probiotic Effectiveness
 
Although often discussed alongside probiotics, prebiotics and synbiotics represent distinct yet complementary strategies for supporting gut microbiome health. Rather than introducing live microorganisms, these interventions focus on nourishing and sustaining beneficial gut bacteria, thereby improving microbial balance and resilience.
 
Prebiotics
 
Prebiotics are non-digestible dietary components—primarily fibers and oligosaccharides—that selectively stimulate the growth and activity of beneficial gut microbes. Unlike probiotics, which add live bacteria to the gut, prebiotics act as nutritional substrates that promote the proliferation of health-supporting species.
 
Common prebiotic compounds include:
  • Inulin
  • Fructooligosaccharides (FOS)
  • Galactooligosaccharides (GOS)
 
These compounds are naturally present in foods such as garlic, onions, bananas, asparagus, legumes, and whole grains. Prebiotics preferentially nourish beneficial bacteria—particularly Bifidobacterium and Lactobacillus species—helping to increase microbial diversity, enhance short-chain fatty acid (SCFA) production, and suppress the growth of potentially harmful microbes.
 
Synbiotics
 
Synbiotics combine probiotics and prebiotics in a single formulation, designed to work synergistically. In synbiotic products, the prebiotic component supports the survival, colonization, and metabolic activity of the included probiotic strains, increasing the likelihood that they reach the gut in sufficient numbers and exert beneficial effects.
 
For example, a synbiotic may pair a specific Bifidobacterium strain with its preferred substrate, such as FOS. This targeted pairing can amplify health benefits, including:
  • Improved gut barrier function
  • Enhanced immune modulation
  • Reduced inflammation
  • Support for metabolic health
 
Practical Use in Gut Health Strategies
 
Prebiotics and synbiotics are often used alongside probiotics to maximize therapeutic effectiveness. Incorporating prebiotic-rich foods or supplements can create a more favorable intestinal environment for probiotics, while synbiotic products simplify this approach by delivering both components together in defined combinations.
 
Together, probiotics, prebiotics, and synbiotics address different but complementary aspects of gut health—from supporting digestion and immune function to reducing inflammation and potentially lowering disease risk. Their thoughtful, targeted use is increasingly recognized as a cornerstone of microbiome-based preventive care.
 
Looking Ahead
 
For individuals with established diseases strongly associated with gut dysbiosis, dietary and supplement-based interventions may not be sufficient. In such cases, the most comprehensive microbiome-based intervention--fecal microbiota transplantation (FMT)—may be considered, as discussed in the following section.
Fecal Microbiota Transplantation (FMT): A Therapeutic Option for Microbiome-Linked Diseases
 
Fecal microbiota transplantation (FMT) is an advanced microbiome-based therapy in which processed stool from a carefully screened healthy donor is introduced into a recipient’s gastrointestinal tract to restore microbial diversity and function. Unlike dietary interventions, probiotics, or synbiotics, FMT directly replaces a disrupted microbial ecosystem, targeting dysbiosis as a root contributor to disease rather than merely modulating symptoms [1].
Picture
Established and Emerging Clinical Applications

FMT has demonstrated its strongest and most consistent efficacy in the treatment of recurrent Clostridioides difficile infection (CDI)—a severe condition characterized by antibiotic-induced microbiome collapse, inflammation, and debilitating diarrhea. In patients who fail standard antibiotic therapy (e.g., vancomycin or fidaxomicin), FMT achieves sustained cure rates exceeding 85%, dramatically reducing relapse and healthcare utilization.
 
Beyond CDI, a growing body of research suggests broader therapeutic potential in diseases linked to gut dysbiosis [2]:
  • Inflammatory Bowel Disease (IBD):
    In ulcerative colitis and Crohn’s disease, FMT has shown the ability to induce remission or reduce disease activity in subsets of patients. Outcomes remain variable and appear highly dependent on donor selection, disease phenotype, and treatment protocols.
  • Irritable Bowel Syndrome (IBS):
    Several studies report symptom improvement and enhanced quality of life following FMT, though results are heterogeneous and not yet definitive.
  • Metabolic Disorders:
    Early investigations into obesity, insulin resistance, and metabolic syndrome suggest that microbiome restoration may influence metabolic pathways, but larger controlled trials are needed.
  • Neurological and Neurodevelopmental Conditions:
    Preliminary studies in Parkinson’s disease and autism spectrum disorders explore FMT through the lens of the gut–brain axis, proposing that microbial modulation may influence neuroinflammation and neurotransmitter signaling.
 
Advantages of FMT
 
FMT offers several distinct advantages over conventional microbiome-modulating strategies:
  1. Comprehensive microbiome restoration
    It reintroduces a diverse and functional microbial ecosystem, overcoming the limited and strain-specific effects of probiotics or dietary changes.
  2. Superior efficacy in recurrent CDI
    FMT consistently outperforms antibiotics, with lower relapse rates and reduced selective pressure for antimicrobial resistance.
  3. Mechanism-based intervention
    By correcting dysbiosis directly, FMT addresses an upstream driver of disease rather than downstream inflammatory consequences.
 
Safety, Regulatory, and Practical Considerations
 
Despite its promise, FMT remains subject to important regulatory, safety, and standardization challenges [3]. Although generally well tolerated, patients may experience transient adverse effects such as abdominal discomfort, bloating, fever, or—rarely—bacteremia. More serious risks include the transmission of undetected pathogens or unanticipated immune effects, underscoring the need for rigorous donor screening and clinical oversight [4].
 
FMT outcomes are also influenced by variables that are not yet fully understood, including donor microbiome composition, delivery method, disease indication, and host immune status [5]. Long-term safety data remain limited, and the potential for unintended metabolic or immune consequences over time continues to be evaluated.
 
Consequently, FMT is typically reserved for patients who have failed standard therapies, rather than used as a first-line intervention.
 
Access to FMT: Clinical and Regulatory Pathways
 
Patients and clinicians seeking FMT as a therapeutic option can access it through several regulated pathways:
  • FDA-approved microbiota-based therapies
    Two prescription products--Rebyota® and Vowst®—are approved for preventing recurrent CDI in adults following antibiotic treatment [6,7].
  • Investigational stool banks
    Organizations such as OpenBiome provide standardized donor material for investigational use under physician supervision.
  • Professional guidelines
    The American Gastroenterological Association (AGA) offers evidence-based clinical guidelines covering indications, donor screening, administration routes, and patient selection [8].
  • Clinical trials
    Ongoing studies listed on ClinicalTrials.gov continue to explore new indications, formulations, and delivery methods for FMT.
 
These resources help ensure that FMT is applied safely, ethically, and effectively within an evolving regulatory framework.
 
Final Perspective
 
FMT represents the most powerful intervention currently available for correcting severe gut dysbiosis. Its success in recurrent CDI has already transformed clinical practice, and expanding evidence suggests broader relevance across inflammatory, metabolic, and neurological diseases. However, widespread adoption will require continued progress in mechanistic understanding, long-term safety evaluation, and protocol standardization.
 
As microbiome science matures, FMT may evolve from a specialized rescue therapy into a cornerstone of precision, microbiome-informed medicine, complementing lifestyle interventions, diet, probiotics, prebiotics, and synbiotics in a truly integrative approach to gut health.
​
References
[1] Karimi M, Shirsalimi N, Hashempour Z, Salehi OH, Sedighi E, Beigi F, Mortezazadeh M. Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. Frontiers in Immunology. 2024, 15.  https://doi.org/10.3389/fimmu.2024.1439176
[2] Goldenberg, D, Melmed, GY. Fecal Transplant: The Benefits and Harms of Fecal Microbiota Transplantation. 2023; In: Pimentel M, Mathur R, Barlow GM (eds) Clinical Understanding of the Human Gut Microbiome. Springer, Cham. https://doi.org/10.1007/978-3-031-46712-7_9
[3] AAMC News: The potential and pitfalls of fecal transplants
[4] Goloshchapov OV, Olekhnovich EI, Sidorenko SV et al. Long-term impact of fecal transplantation in healthy volunteers. BMC Microbiol. 2019; 19, 312. https://doi.org/10.1186/s12866-019-1689-y
[5] Lee JY, Kim Y, Kim J et al. Fecal Microbiota Transplantation: Indications, Methods, and Challenges. J Microbiol. 2024. https://doi.org/10.1007/s12275-024-00184-3
[6] AGA: FDA approves first FMT therapy and issues guidance, December 2, 2022
[7] Vowst® (Seres Therapeutics)
[8] AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases. Peery AF. et al. Gastroenterology. 2024; 166 (3): 409 – 434. https://doi.org/10.1053/j.gastro.2024.01.008
Post blog note
​Top 5 Probiotics for Your Digestive and Immune Health
Top Probiotic Strains:
  • Bifidobacterium breve improves brain function, enhances immunity, and helps digest gluten*.
  • Bifidobacterium lactis promotes wound healing and enhances immunity*.
  • Lactobacillus acidophilus found to improve gut health and combats harmful bacteria*.
  • Lacticaseibacillus rhamnosus improves immune function and mood*.
  • Ligilactobacillus salivarius supports oral health and enhances immunity*.
  • Saccharomyces boulardii found to help reduce bowel issues from antibiotics and H. pylori*.
0 Comments



Leave a Reply.

    Author & Editor

    Hung V. Le PhD
    ​

    Archives

    April 2026
    March 2026
    February 2026
    January 2026
    December 2025
    November 2025
    October 2025
    August 2025
    June 2025
    March 2025
    February 2025
    January 2025
    December 2024
    September 2024
    August 2024
    June 2024
    May 2024
    March 2024
    February 2024
    January 2024
    November 2023

    Categories

    All

    RSS Feed

Preventive medicine plays a crucial role in enhancing public health by focusing on proactive measures to avoid illness. By promoting healthy lifestyles, vaccinations, and early screenings, it significantly reduces the burden on healthcare systems and improves overall quality of life. It empowers individuals to take charge of their well-being and fosters a healthier, more sustainable society.